Nuovi scenari nell’iperparatiroidismo secondario: etelcalcetide : Position Paper dei Nefrologi lombardi [New scenarios in secondary hyperparathyroidism: etelcalcetide. Position paper of Nephrologists form Lombardy]
Articolo
Data di Pubblicazione:
2018
Citazione:
Nuovi scenari nell’iperparatiroidismo secondario: etelcalcetide : Position Paper dei Nefrologi lombardi [New scenarios in secondary hyperparathyroidism: etelcalcetide. Position paper of Nephrologists form Lombardy] / A. Bellasi, M. Cozzolino, F. Malberti, G. Cancarini, C. Esposito, A. Genderini, C.M. Guastoni, P. Ondei, G. Pontoriero, U. Teatini, G. Vezzoli, P. Messa, F. Locatelli. - In: GIORNALE ITALIANO DI NEFROLOGIA. - ISSN 1724-5990. - 35:3(2018 May).
Abstract:
Bone mineral abnormalities (defined as Chronic Kidney Disease Mineral Bone Disorder; CKD-MBD) are prevalent and associated with a substantial risk burden and poor prognosis in CKD population. Several lines of evidence support the notion that a large proportion of patients receiving maintenance dialysis experience a suboptimal biochemical control of CKD-MBD. Although no study has ever demonstrated conclusively that CKD-MBD control is associated with improved survival, an expanding therapeutic armamentarium is available to correct bone mineral abnormalities. In this position paper of Lombardy Nephrologists, a summary of the state of art of CKD-MBD as well as a summary of the unmet clinical needs will be provided. Furthermore, this position paper will focus on the potential and drawbacks of a new injectable calcimimetic, etelcalcetide, a drug available in Italy since few months ago.
Tipologia IRIS:
01 - Articolo su periodico
Keywords:
CKD-MBD; cinacalcet; PTH; etelcalcetide; secondary hyperparathyroidism
Elenco autori:
A. Bellasi, M. Cozzolino, F. Malberti, G. Cancarini, C. Esposito, A. Genderini, C.M. Guastoni, P. Ondei, G. Pontoriero, U. Teatini, G. Vezzoli, P. Messa, F. Locatelli
Link alla scheda completa:
Link al Full Text: